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380 The Journal of Thoracic and CardioObjective: The purpose of the study was to determine technical and clinical results
in endovascular repair of thoracic aortic diseases necessitating stent-graft anchoring
across the arch vessels.
Methods: The causes for endovascular treatment in 58 patients (aged 20 to 84 years)
were aneurysms (n  32), acute type A (n  2) and type B dissections (n  17),
posttraumatic transections (n  4), iatrogenic dissection (n  1), and penetrating
ulcers with an intramural hematoma (n  2). Surgical revascularization of arch
vessels was performed in 26 patients before stent-graft implantation. Intentional
overstenting of the left subclavian artery resulted in complete occlusion in 8 and was
partial in 24 patients.
Results: The 30-day mortality rate was 3.4%. Overall, 19 major postprocedural
complications occurred in 14 (24%) patients. Among patients with left subclavian
artery occlusion, 2 patients had major (1 paraplegia, 1 critical arm ischemia), and 3
minor (2 temporary vertebrobasilary symptoms, 1 transient arm claudication) com-
plications. Fourteen (25%) patients had an early endoleak, of whom 5 were treated
successfully with a secondary endovascular procedure, 2 necessitated open surgical
conversion, and 7 were treated conservatively, with spontaneous sealing of the
endoleak in 3. In 53 (91%) in whom computed tomographic follow-up was longer
than 3 months (mean, 30.1 months, range, 3 to 85), the aortic diameter along the
stented segment decreased in 24, was stable in 19, and increased in 10 patients.
Conclusion: Fixation of the stent graft in the aortic arch can expand the applicability
of endovascular repair. Intentional overstenting should be performed with caution to
avoid ischemic problems after complete occlusion of left subclavian artery.
Since the first endovascular application of a self-fixing synthetic prosthesis forthe treatment of a traumatic thoracic aortic aneurysm by Volodos and asso-ciates1 in 1988, this less invasive procedure became an alternative modality
to open surgical repair in a selected population of patients. Several studies suggest
that this endovascular treatment modality may reduce postoperative morbidity and
mortality rates, as well as hospital stay.2,3 However, successful stent-graft placement
requires a satisfactory landing zone of at least 15 mm in length.4 Although various
pathologies begin just distal to the left subclavian artery (LSA) or include the distal
arch, innovative techniques have extended endovascular treatment options. Over-
stenting of the left subclavian artery has been performed without acute adverse
events to elongate the proximal landing zone.5-7 However, delayed onset of verte-
brobasilary insufficiency and arm ischemia has been reported.8,9 Bypass surgery or
transposition of aortic arch vessels before stent-graft repair is sometimes mandatory
to preserve blood flow or to prevent type II endoleaks.10,11 Alternatively, initial
clinical experiences with branched stent grafts have been reported.12,13
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CDThis report presents the results of our experience with
treatment of thoracic aortic diseases necessitating stent-graft
placement across the origin of arch vessels. Evaluation was
focused on management of aortic arch vessels and clinical
consequences. Furthermore, frequency of endoleaks related
to the landing zone and change of aortic size in the stented
segment were evaluated.
Material and Methods
Patient Evaluation
Between November 1996 and April 2004, at total of 107 patients
were treated with endovascular repair. Fifty-eight (54%) patients
who required anchoring of the stent graft at the origin of arch
vessels were included in this study. There were 13 women and 45
men with a mean age of 61.8 years (range, 20 to 84 years). The
associated comorbidities are listed in Table 1. Fixation in the aortic
arch was performed in 32 patients with aneurysms (25 atheroscle-
rotic aneurysms, 4 chronic posttraumatic aneurysms, and 3 aneu-
rysms related to previous surgery for coarctation). Furthermore,
there were 2 patients with acute type A and 17 patients with acute
type B dissections. One patient had an iatrogenic dissection, 4
patients had a posttraumatic transection, and 2 patients had
penetrating atherosclerotic ulcers (PAUs) and an intramural he-
matoma (IMH).
Of the 58 patients, 19 (32.8%) had associated complications.
Eleven of the 19 (57.9%) required emergency stent grafting for
treatment of aortic rupture (n  1), contained rupture (n  6), or
compromised aortic branches (n  4). The remaining 8 patients had
complications that required urgent but not emergency treatment.
Indication for stent grafting in aneurysms (n  32). Of 25
patients with atherosclerotic aneurysms, 3 (12%) presented with a
contained rupture necessitating emergency stent grafting. In the
remaining patients, an American Society of Anesthesiology (ASA)
class of at least III was the indication for elective endovascular
repair. Furthermore, 5 patients had a history of cardiac (n  1) or
thoracic aortic surgery (n  4).
Indication for stent grafting in dissections (n  20). In pa-
tients with a type A dissection (n  2), additional stent grafting
was required after surgical replacement of the ascending aorta
because of a compromised iliac artery in 1 patient. To prevent further
dilatation of the thoracic aortic diameter, we placed an additional
stent graft in the second patient who presented with an aortic
diameter of more than 40 mm, flow within the false lumen due to
an intimal tear close to the left subclavian artery, and compression
Abbreviations and Acronyms
ASA American Society of Anesthesiologists
CCA common carotid artery
CT  computed tomography
CTA computed tomography-angiography
IMH  intramural hematoma
LSA  left subclavian artery
PAU penetrating atherosclerotic ulcer
VA  vertebral arteryof the true lumen.
The Journal of ThoraciOf patients with an acute type B dissection (n  17), 13 (76.5%)
were treated because of one or more associated complications
(Table 2). In 4 asymptomatic acute type B dissections with an
aortic diameter of more than 40 mm, a patent false lumen, and
marked compression of the true lumen, stent grafting was per-
formed to prevent progression of dissection and aneurysmal
degeneration.
One patient with an iatrogenic dissection was treated to prevent
progression of dissection.
Indication for stent grafting in other thoracic aortic diseases
(n  6). Patients with a posttraumatic transection (n  4) pre-
sented with multiple serious injuries. Additionally, one patient had
a contained rupture with a mediastinal hematoma. Among patients
with a PAU/IMH (n  2), 1 patient who had poorly manageable
hypertension was treated to prevent deterioration and the other was
treated for a contained rupture.
In our institution, endovascular repair of thoracic aortic dis-
eases has been considered as an alternative treatment to surgical
repair in high-risk patients since 1996. Written informed consent
was obtained from all conscious patients. In emergency situations
and with unconscious patients, endovascular treatment was an
interdisciplinary decision.
Patients were selected for endovascular repair on the basis of
contrast-enhanced computed tomography (CT)-angiography (CTA)
using either a single-detector (Somatom Plus 4; Siemens, Erlan-
gen, Germany) or a multidetector (Somatome Volume Zoom;
Siemens) scanner. CT scanning ranged from the supra-aortic ves-
sels to the common femoral arteries. Three-dimensional recon-
struction (multiplanar reconstruction, curved planar reconstruc-
tion, maximum-intensity projection) were processed from each CT
scan.
In 9 patients with atherosclerotic aneurysms, the origin of the
TABLE 1. Comorbidities in 58 patients with thoracic aortic
aneurysm or dissection who were treated by endovascular
repair
Associated medical problems No. of patients Percent
Hypertension 43 74
Coronary artery disease 7 12
Previous cardiac infarction 3 5
COPD 6 10
Renal impairment 15 26
Mild-moderate 11 19
Severe 4 7
Diabetes mellitus 12 21
One occluded internal carotid artery 2 3
Previous stroke 2 3
Malignancy 4 7
Previous cardiac or aortic surgery 7 12
ASA scores
Class III 42 72
Class IV 8 14
Class V 8 14
COPD, Chronic obstructive pulmonary disease. Mild-moderate renal failure 
serum creatinine concentration 1.4-2.5 mg/dL; severe renal failure 
serum creatinine concentration 2.5 mg/dL.LSA was in the aneurysm. The remaining patients had a distance
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dissection of less than 15 mm (ranging from 0 to 14 mm).
According to the proposed classification of landing zones by
Mitchell and coworkers,14 required proximal stent-graft attach-
ments were classified within the 3 zones: zone 0 (includes the
origin of brachiocephalic trunk), zone 1 (includes the origin of the
left common carotid artery [CCA]), and zone 2 (includes the origin
of LSA).
To avoid ischemic adverse events, primary surgical revascular-
ization of the LSA was performed in patients with a dominant left
vertebral artery (VA), with a marked stenosis of the origin of the
right VA, or an occluded internal carotid artery. Intentional over-
stenting of the LSA without previous revascularization was per-
formed in patients who had a good and an equal caliber of both
VAs. Blood flow within the CCAs was preserved by either trans-
position or bypass surgery.
Endovascular Prosthesis and Procedure
In 30 patients a Talent endoprosthesis (Medtronic, Sunrise, Fla)
was implanted. The Thoracic Excluder (W. L. Gore & Associates,
Inc, Flagstaff, Ariz) was used in 27 patients and an Endofit
endoprosthesis (Endomed, Phoenix, Ariz) in 1 patient. The diam-
eter of the stent graft was calculated from the largest diameter of
the proximal or distal neck and an oversizing factor of 10% to 20%
was added.
Procedures were performed in the angiography suite, which is
equipped with digital subtraction angiography (Multistar T.O.P.;
Siemens). Treatment was performed with the patients under gen-
eral or epidural anesthesia. After surgical cutdown of the femoral
or iliac artery (n 52) or the infrarenal aorta (n 6), an antibiotic
prophylaxis and 5000 IU of heparin sodium were administered
intravenously. To perform angiograms immediately before stent-
graft release, we positioned a pigtail catheter in the ascending aorta
via a percutaneous left or right brachial access. The stent-graft
system was inserted over a super stiff guide wire (Back-up Meier,
Boston Scientific Corp., Natick, Mass) and deployed using an overlay
imaging technique in at least 40° left anterior oblique view. Sys-
tolic pressure was pharmacologically lowered to 60 mm Hg during
prosthesis deployment. To improve expansion and the friction seal,
we used an appropriate-sized latex balloon (Thoracic Excluder
balloon catheter; W. L. Gore & Associates; Reliant balloon,
Medtronic, Sunrise, Fla) for modeling the proximal and distal end
TABLE 2. Associated complications of acute type B disse
Complications 1 2 3 4
Rupture Y
Contained rupture Y
Compromised visceral arteries Y Y
Compromised iliac arteries Y
Refractory hypertension Y
Pleural effusion Y Y
Rapid progression of diameter Y
Continuing pain Y
Y, Presence of clinical symptoms and radiologic findings.of the stent graft to the aortic wall in all aneurysms. To avoid
382 The Journal of Thoracic and Cardiovascular Surgery ● Febrcreation of additional entry tears in type B–dissections, we pre-
ferred to leave the attachment zones without balloon inflation.
Finally, completion angiograms were performed.
Follow-up
Routinely, CTA was performed before hospital discharge, at 3, 6,
and 12 months, and annually thereafter. In patients with an aortic
dissection, 1 acquisition, including intrathoracic arch vessels and
iliac arteries, was performed. In patients with aneurysms, addi-
tional late acquisitions with a 30-second interscan delay were made to
rule out small endoleaks. In patients with impaired renal function,
magnetic resonance imaging was conducted for follow-up.
Follow-up measurements of the maximum aortic diameter at
the stented segment were performed perpendicular to the axis of
the vessel.
Statistical Analysis
A minimum follow-up of 3 months was required to evaluate
changes of the aortic size. To overcome the variability in mea-
surements, we considered a change of diameter to be significant
when there was a difference of 4 mm or more as compared to the
first postprocedural CTA, as previously described.15 Continuous
variables are expressed as means  standard deviation.
For statistical analysis concerning the frequency of proximal
attachment endoleaks after stent-graft repair of aneurysms, pa-
tients were divided into group I (anchoring zone 0 and 1) and
group II (anchoring zone 2). Differences were tested for signifi-
cance using the 2 test for proportions. Statistical analysis was
performed using a statistical software package (SPSS Rel. 13;
SPSS Inc, Chicago, Ill).
Results
Technical Results
Before stent graft implantation, a bypass was created to 1
(LSA, n 1) or 2 (brachiocephalic trunk and left CCA, n
1, and left CCA and LSA, n  2) arch vessels. Before
endovascular repair, the LSA was transposed solely (n 
17) or in combination with transposition of the left CCA
(n  5). In patients without previous revascularization of
the LSA, the origin was completely occluded in 8 and
in 13 symptomatic patients
Patient
6 7 8 9 10 11 12 13
Y Y
Y Y
Y Y Y
Y Y Y Y Y
Y Y
Yction
5
Y
Ypartially overstented in 24 patients.
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CDStent-graft anchoring in zone 0 was necessary in 9 pa-
tients. All had an atherosclerotic aneurysm involving the
distal arch. After surgical revascularization, the origin of the
left CCA (n  6), the LSA (n  6), and the brachiocephalic
trunk (n  1) was overstented. In 3 patients the LSA was
covered without revascularization. Three patients had a left
CCA origin at the brachiocephalic trunk. In 13 patients the
bare springs (Talent endoprosthesis) or flairs (Excluder en-
doprosthesis) were positioned in zone 1 (7 aneurysms, 5
dissections, 1 posttraumatic transection; Figure E1). The
origin of the left CCA (n  2) and the LSA (n  8) was
overstented after surgical revascularization in 8 patients. In
another 5 patients the LSA was covered completely (n  2)
or partially (n  3) without prior revascularization. In 36
patients the fixation of the stent graft was in zone 2 (16
aneurysms, 15 dissections, 3 posttraumatic transections, 2
PAU/IMH). The LSA was overstented after surgical revas-
cularization in 11 patients. Complete LSA overstenting
(n  3) and partial LSA overstenting (n  21) were per-
formed without surgical revascularization in this group. In 1
patient only the bare springs were anchored over the LSA
origin.
Deployment of stent grafts was technically successful in
all patients. However, due to distal retraction of the stent
graft into the aneurysm sac during deployment or dilation or
to inadequate sealing between segments, immediate intra-
procedural overstenting was required in 7 patients.
In aortic dissections closure of the entry tear and expan-
sion of the true lumen after stent-graft deployment resulted
in satisfactory reperfusion of compromised visceral or iliac
arteries in 7 of 9 patients. A residual obstruction of the
superior mesenteric artery in 1 patient, and of the iliac artery
in a second patient, was additionally treated with placement
of an uncovered stent into the true lumen of these vessels.
Clinical Outcome and Survival
Two (7.7%) patients had complications after surgical revas-
cularization of arch vessels before the endovascular proce-
dure. One patient had Horner’s syndrome, and the second
patient had hoarseness due to recurrent laryngeal nerve
injury that resolved over time.
After the stent-graft procedure, 19 major postprocedural
complications occurred in 14 (24%) patients and led to
death in 2, resulting in a perioperative mortality rate of
3.4%. One patient with type B dissection died of pericardial
tamponade after retrograde type A dissection on day 9 after
endovascular repair. The second patient with a ruptured type
B dissection and primarily successful occlusion of the entry
tear died because of rerupture during surgical evacuation of
the hemothorax. A retrograde type A dissection occurred in
another 2 patients with an atherosclerotic aneurysm in 1 and
an acute type B dissection in the other. Both patients were
treated successfully by surgical repair.
The Journal of ThoraciFurther major complications were hemorrhage at the
access site (n  2), requiring surgical revision in both
patients. One of these had hypovolemic shock, which was
accompanied by prolonged intubation and hemodialysis.
Prolonged intubation was necessary in a second patient
because of lung atelectasis and in a third patient with severe
gastrointestinal bleeding due to heparin-induced thrombo-
cytopenia who also required hemodialysis. Three (5.2%)
patients without occlusion of the LSA had a stroke with
transient neurologic deficits. Two patients had a right-sided
cerebral infarction. The third patient whose LSA was revas-
cularized by a carotid-subclavian bypass had an infarction
in the territory of the posterior cerebral artery on both sides
after LSA overstenting. Spinal cord ischemia with tempo-
rary paraparesis occurred in 2 patients with incomplete
overstenting of the LSA, and in whom the stent graft was
fixed distally at the level of the seventh and ninth thoraco-
lumbar vertebrae (Th7 and Th9). A permanent paralysis
occurred in 1 patient whose LSA was overstented and the
device covered Th8 distally. Critical arm ischemia devel-
oped in 1 patient after complete occlusion of the LSA,
necessitating transposition of the LSA.
Regarding patients with complete occlusion of LSA, 5 of
8 (63%) presented with adverse events. Two patients had
major periprocedural complications (1 paraplegia, 1 critical
arm ischemia). Minor complications occurred in 3 patients
(2 incomplete subclavian steal syndromes with temporary
dizzy spells, 1 with temporary arm claudication).
Among patients with partial covering of the LSA, 1 (4%)
of 24 patients had transient attacks of dizziness.
CTA Follow-up in Thoracic Aortic Aneurysms
At the first postprocedural CTA 12 (37.5%) of 32 patients
presented with an endoleak. Type of endoleaks, manage-
ment, and CT follow-up data are listed in Table 3. In 7
(21.9%) patients incomplete sealing at the proximal attach-
ment zone (type Ia endoleak) occurred. Comparing the
frequency of type Ia endoleaks in aneurysms, there was a
higher rate in group I (including zone 0 and 1) than in group
II (zone 2; P  .344). Five (15.6%) patients had an incom-
plete sealing between segments (type III endoleak), leading
to disconnection of segments in 2. In 1 of these patients,
endovascular treatment failed due to severe kinking of the
thoracic aorta. Because of comorbidities, this patient was
refused for surgical conversion. The second patient refused
any further treatment.
An early reperfusion of the aneurysm sac from side
branches (type II endoleak) was detected before hospital
discharge in 2 patients. The type II endoleak, caused by
intercostal arteries, remained in 1 patient who also had a
type III endoleak, which was treated successfully by over-
stenting. In the second patient, who had a type II endoleak
through thyrocervical branches, enlargement of the aneu-
c and Cardiovascular Surgery ● Volume 131, Number 2 383
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tion of these branches failed.
Two outpatients were lost to follow-up CT examinations.
During a mean observation period of 36.4  26.7 months
(range, 3 to 85 months) a late endoleak was detected in 3
(10%) of 30 patients. A type II endoleak occurred in 1 patient
after overstenting of the LSA and required LSA transposi-
tion. In 1 patient with a sealed primary endoleak (patient 8),
who was treated with an Excluder endoprosthesis, a small
midgraft endoleak developed (related to a fabric tear), which
was detected at the 5-year CT follow-up. After an initial
decrease of the aneurysm sac within the first 4 years, this
endoleak caused enlargement of the aneurysm to the origi-
nal size. Because of an inappropriate access site for endo-
vascular repair and his high surgical risk, this patient is
under observation without further intervention. In the third
patient, an endoleak developed at the distal attachment site
due to aneurysm growth caused by a primary type II endoleak
(patient no. 10). The patient was successfully treated by em-
bolization of intercostal arteries and distal overstenting.
During the follow-up period, 22 (73.3%) of patients were
without a visible endoleak at any time or a sealed primary
endoleak. In these patients, mean decrease of the aneurysm
size was 15 8 mm (range, 5 to 27 mm) in 10 patients. The
aneurysm size remained stable in 10 patients, but 2 patients
showed a substantial increase (41 and 15 mm) of the aneu-
rysms sac (type V endoleak–endotension). With CT-guided
puncture of the aneurysm sac in 1 of the latter patients,
straw-colored fluid was aspirated. Overstenting of the pros-
thesis was performed in both patients. During a 2-month
follow-up period, the aneurysm size in both patients de-
creased by 14 mm and 3 mm, respectively.
CTA Follow-up of Aortic Dissections, PAU/IMHs, and
Posttraumatic Transections
At the first postprocedural CTA, 2 (8.3%) of 24 patients
presented with an early endoleak. In 1 patient with an
iatrogenic dissection, the entry tear next to the LSA could be
closed by proximal overstenting in a second procedure. In
the second patient with a traumatic transection, a fabric tear
in the expanded polytetrafluoroethylene (ePTFE) membrane
of the Excluder was identified, which was also treated
successfully by overstenting.
One outpatient was lost to CTA follow-up examinations.
Overall, 23 (88.5%) patients had a mean CT follow-up of
21.9  15.3 months (range, 4.6 to 52.7).
In patients with a type A or B dissection, the false lumen
along the stented thoracic aortic segment was thrombosed in
all but 1 (94%). Expansion of the stent graft resulted in a
mean diameter increase of the true lumen of 19  7.7 mm,
and the false lumen resolved completely in 10 (59%) pa-
tients. The false lumen distal to the stent graft thrombosed
in 10 (59%) of 17 patients in the thoracic segment and in 3
(20%) of 15 patients in the abdominal aortic segment.
384 The Journal of Thoracic and Cardiovascular Surgery ● FebrThe intramural hematoma in both patients with penetrat-
ing ulcers resolved completely during the observation period.
In traumatic dissections, the aortic diameter decreased in
1 patent and was stable in 3.
Discussion
Over the past 10 years, endovascular stent-graft repair of
atherosclerotic thoracic aortic aneurysms5,16 and dissections,
including atherosclerotic penetrating ulcers17,18 and trau-
matic7,10 and type B dissections,6,19 has proven to be a
promising, less invasive treatment modality than open sur-
gical repair. However, in aortic abnormalities that are close
to the LSA or include the distal arch, one of the most
difficult and challenging aspects is the absence of an ade-
quate proximal anchoring zone for secure fixation of the
device. Different strategies for lengthening of the proximal
landing zone are reported in the literature and were followed
in our patients.
In a few series, simple overstenting of the LSA6,20-22 is
reported as a feasible and well-tolerated procedure for fix-
ation of the stent graft. In the study group of Görich and
coworkers21 with incomplete overstenting of LSA in 4 and
complete occlusion of the LSA in 19 patients, 22 patients
had at least a 1-month follow-up. From those, 3 (13.6%)
patients reported ischemic arm symptoms but none of the
patients had persistent signs of vertebrobasilary insuffi-
ciency. On the other hand, in the series of Tiesenhausen and
associates,9 3 (37.5%) of 8 patients with partial or complete
occlusion of LSA had vertebrobasilar symptoms.
In our study group, only 2 (25%) of 8 patients with
complete occlusion of the overstented LSA were without
symptoms at any time. Secondary transposition of LSA was
necessary in 2 patients, 1 for treatment of critical arm
ischemia and 1, an endoleak.
As known from the literature, most patients with athero-
sclerotic subclavian artery stenosis or occlusions are clini-
cally asymptomatic.23,24 However, slow progression of sub-
clavian stenosis promotes collateral vessel development
from the thyrocervical and external carotid arteries.25 In
acute LSA occlusion lack of collateral pathways might
result in ischemic symptoms in a considerable number of
patients as shown in our study. As reported in the litera-
ture,26 occlusion of 1 VA caused vertebrobasilary ischemia
resulting in cerebellar infarction in 2.7%. This ischemic
event might be related to the ability of the contralateral VA
to supply blood to the posterior circulation. Furthermore,
bilateral VA occlusion, which can be also simulated by
overstenting of the LSA and an additional severely stenotic
or hypoplastic right VA, caused irreversible neurologic
problems in 23% of patients. In case of atherosclerotic
diseased supra-aortic vessels, the presence of multilevel
disease involving both the CCAs and VAs was reported in
87%.23 Therefore, to avoid infarction, a noncompromised
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via the posterior communicating artery seems to be essen-
tial.26,27 To minimize the risk for ischemic disorders, one
should evaluate the CCA and VA, as well as the circle of
Willis, before intentional LSA occlusion. Moreover, ana-
tomic variants, such as origin of the left VA at the arch or
a nonexisting fusion of the VAs to the basilary artery, do not
allow LSA occlusion without previous revascularization. To
minimize disadvantages after LSA overstenting, we changed
our CTA protocol recently and now start the evaluation at
the level of the circle of Willis. Another aspect of preserving
optimized blood flow within the LSA is to provide sufficient
flow into the left internal thoracic artery to enable bypass
surgery in patients with a coronary artery disease.
Another indication for transposition of the LSA or LSA-
to-left CCA bypass surgery followed by ligation of the LSA
is to avoid retrograde perfusion of the aneurysm sack in
distal arch aneurysms, as happened in one of our patients, or
to avoid retrograde perfusion of the false lumen in dissec-
tions as reported by Tiesenhausen and colleagues.9
If complete overstenting of the LSA is necessary and
there is any concern for potential ischemic events, it is our
intention to revascularize the LSA in advance rather than in
a secondary procedure. Surgical complications of LSA trans-
position in our series were transient symptoms of Horner
syndrome and hoarseness in 2 (7.1%) of 28 patients. Low
morbidity rates in subclavian artery revascularizations are
also reported in the literature.23,24 Alternatively, to maintain
arch vessel perfusion, branched stent grafts have been
devised in a few studies.12,13 In the series of Inoue and
associates,12 one third of patients had major complications,
and primary exclusion of the aneurysm was achieved in
60% only. This result clearly demonstrates the difficulty and
complexity of endovascular repair of distal arch aneurysms.
TABLE 3. Management and CT follow-up of primary endol
Pts
Anchoring
zone
Arch vessel
revascularization
Primary
endoleak Reinterve
1 0 Bypass to LCCA  LSA III No
2 0 LSAT III Balloon
3 0 LSAT  LCCAT Ia No
4 0 LSAT  LCCAT Ia, III No
5 0 LSAT  LCCAT Ia No
6 1 LSAT III No
7 1 LSACO Ia Balloon
8 1 LSAT  LCCAT Ia No
9 2 LSAPO Ia Overste
10 2 LSAPO II, III Overste
11 2 LSAT Ia No
12 2 LSAPO II Emboliz
Pts, patients; LCCA, left common carotid artery; LSA, left subclavian arter
overstenting; LSAPO, LSA partial overstenting. *Patient had a late type III endo
The Journal of ThoraciIn the present study, the 30-day mortality was 3.4%. Of
particular concern was the death due to retrograde type A
dissection, which happened on day 9 after stent-graft repair.
Overall, 3 of our patients who were treated either with the
Gore or the Talent endoprosthesis had retrograde dissec-
tions. Therefore, we believe that the proximal bare springs
(Talent endoprosthesis) are not the only reason for wall
damage, as suspected by Orend and colleagues.7 The lim-
ited flexibility of the devices might produce forced wall
stress at the outer curvature leading to intimal injuries as
reported in previous series.28,29
Paraparesis and paraplegia occurred in 5.1% of our pa-
tients, which is higher than in other reported studies.7,30
However, spinal cord ischemia only occurred after treat-
ment of acute dissections. One of these patients additionally
had an intentional overstenting of the LSA. Therefore, LSA
occlusion with interruption of collateral pathways to the
spinal artery might lead to a higher risk for paraplegia. None
of our patients with atherosclerotic aneurysms had ischemic
spinal cord symptoms, leading to the assumption that col-
lateral vessel formation between intercostals are stimulated
by slow progression of atherosclerotic changes.
The rate of primary endoleaks after endovascular repair
of variant thoracic aortic lesions was reported to be 11% to
20%.3,5,7,11 In our patient group with fixation of the device
in the arch, the first CTA showed a primary endoleak in 12
(37.5%) of 32 patients treated for aneurysms and in 2
(8.3%) of 24 surviving patients with dissections. However,
because of the ongoing tendency of the stent graft to ex-
pand, small endoleaks may seal spontaneously. Thus, de-
layed sealing occurred in 3 of 14 patients, and in 2 the
endoleak decreased under observation. Overall, during the
follow-up period, an additional endovascular procedure was
performed successfully in 5 (71%) of 7 patients with per-
in 12 patients treated for aneurysms
CT follow-up
(d)
Change of
aneurysm
size (mm) CT follow-up of primary endoleaks
2102 34 III Disconnection of segments
10 No No Sealed
99 5 Ia Endoleak decreased
143 No Ia Ia decreased, III sealed
193 No No Sealed
469 19 III Disconnection of segments
582 14 No Sealed
670 16* No Sealed*
2128 20 Ia Surgical conversion
1382 23† II III sealed†
113 No No Sealed
445 16 II Surgical conversion
AT, LSA transposition; LCCAT, LCCA transposition; LSACO, LSA completeeaks
ntion
ing
ing
nting
nting
ation
y; LS
leak. †Patient had a late type Ib endoleak.
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conversion. Two patients with a type III endoleak received
no further treatment.
Comparison of the frequency of type Ia endoleaks in
aneurysms according to zone groups demonstrated a higher
tendency in those patients with anchoring of the device in
the proximal versus the distal arch. Therefore, despite in-
novative techniques to lengthen the proximal attachment
zone, the inability of currently available stent grafts to hug
the curved aortic arch in all instances still remains the
reason for primary incomplete sealing of aneurysms in a
considerable number of patients.
In 2 patients who had no visible endoleaks but a sub-
stantial increase of the aneurysm size, endotension was
assumed. Supported by reports in the literature describing
transudation of fluid through PTFE grafts,31,32 porosity of
the e-PTFE membrane of the Excluder endoprosthesis was
thought to cause a perigraft seroma. Moreover, decrease of
the aneurysm sac in both patients after overstenting con-
firmed our primary hypothesis of graft-porosity.
In conclusion, ancillary techniques in management of
aortic arch vessels can expand the applicability of endovas-
cular repair in thoracic aortic aneurysms and dissections.
However, available devices in the study period were not
flexible enough to hug the aortic arch in all patients.
Intentional overstenting of the LSA resulted in ischemic
disorders in a considerable number of our patients. There-
fore, to reduce unforeseen ischemic problems, accurate
evaluation of supra-aortic arteries is mandatory. Surgical
revascularization of the LSA is recommended in patients in
whom any concern for potential ischemic events exists.
Table 3.
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CDFigure E1. A, Angiogram with a calibrated pigtail-catheter shows origin of the LSA from the aneurysm and a 1 cm
proximal neck to the left carotid artery. B, After transposition of the LSA to the left CCA and the left CCA to the
brachiocephalic trunk, the aneurysm was treated with 3 Talent endoprosthesis (zone 1). C, First CT follow-up
shows a type Ia endoleak at the lesser curvature. D, The 3-month CT follow-up demonstrated spontaneous sealing
of the endoleak.387.e1 The Journal of Thoracic and Cardiovascular Surgery ● February 2006
